DME Competitive Bidding Restarts: What Suppliers Must Know

Medicare’s competitive bidding program is restarting, and the timeline is now public. According to Mobility Management, suppliers can register for the next round beginning Dec. 1, 2026, with registration closing Feb. 1, 2027. The bid window then opens Jan. 5, 2027 and closes March 10, 2027. For distributors, contract pricing resets again — which puts landed cost, product cost structure and documentation quality back at the centre of sourcing decisions. Distributors that quote a rate before understanding their own cost basis rarely recover it later.

According to CMS guidance published on Sept. 29, 2026, a second change took effect on Oct. 15, 2026: CMS began requiring probationary prior authorization for certain DMEPOS items billed by newly enrolled suppliers and by suppliers undergoing certain changes of ownership. In practice, newer providers must clear a pre-claim review before they are paid for affected items. Suppliers carrying thin product documentation absorb that risk, so manufacturers that supply complete specification sheets, verified load ratings and consistent product detail become materially more valuable to a bidding team.

Legislative pressure is moving in parallel. On Oct. 9, 2026, a bipartisan group in the U.S. House introduced the Access to Medical Supplies Act, which seeks a five-year postponement of Medicare competitive bidding for ostomy and urological supplies, as reported by Mobility Management. The lesson for procurement teams is to plan for policy volatility at both ends of the supply chain: bidding resets on one side, coverage and filing rules on the other. For mobility and bathroom-safety suppliers, the signal is that reimbursement rules keep shifting faster than product cycles.

The practical response is preparation rather than prediction. Three steps help distributors protect margin through the next round: audit landed cost per SKU instead of unit price alone; consolidate volume with a bulk mobility aids supplier that can quote before the bid window opens; and confirm that every item ships with documentation that supports prior authorization and claim review. JiNDA Health Care manufactures wheeled walkers with seats, telescopic canes and related mobility aids in aluminium and carbon steel, with ISO 13485 process discipline, OEM/ODM programmes and U.S. local stock for faster replenishment.